Last update 01 Nov 2024

Shanghai Gebaide Biotechnology Co., Ltd.

Joint Venture Company | Private Company|
2011|
Shanghai Shi, China

Overview

Related

1
Drugs associated with Shanghai Gebaide Biotechnology Co., Ltd.
Dulanermin(Shanghai Gebaide Biotechnology Co., Ltd.)
Target
TRAIL receptor
Mechanism
TRAIL receptor agonists [+1]
Active Org.-
Originator Org.
Shanghai Gebaide Biotechnology Co., Ltd.
Active Indication-
Inactive Indication
Advanced Lung Non-Small Cell Carcinoma
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Shanghai Gebaide Biotechnology Co., Ltd.
CTR20161061 / Not yet recruitingPhase 3
注射用重组人凋亡素2配体治疗晚期非小细胞肺癌随机、双盲、安慰剂平行对照、多中心Ⅲ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of recombinant human apoptosis-inducing factor 2 ligand for the treatment of advanced non-small cell lung cancer
NCT03083743 / Unknown statusPhase 3
A Randomized, Double-blind, Placebo-controlled in Parallel, Multicenter Phase III Trial of Recombinant Human Apo-2 Ligand for Injection（Dulanermin for Injection）in the Treatment of Advanced Non-small Cell Lung Cancer
100 Clinical Results associated with Shanghai Gebaide Biotechnology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shanghai Gebaide Biotechnology Co., Ltd.
Login to view more data
100 Deals associated with Shanghai Gebaide Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Gebaide Biotechnology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Dulanermin(Shanghai Gebaide Biotechnology Co., Ltd.)
 ( TRAIL receptor )		Advanced Lung Non-Small Cell Carcinoma
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free